DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ advanced 1.35% to $180.18 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.25% to 6,829.37 and the Dow Jones Industrial Average rising 0.39% to 47,474.46.
Biogen Inc. closed 2.69% short of its 52-week high of $185.17, which the company reached on November 24th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.04% to $205.42, Pfizer Inc. $(PFE)$ fell 0.47% to $25.15, and AbbVie Inc. $(ABBV)$ fell 0.33% to $224.37.
Trading volume (1.9 M) eclipsed its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 02, 2025 17:04 ET (22:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments